Zenocare Pharmaceuticals Private Limited - Company Profile

It is a trading private limited company based in Vadodara, Gujarat, India, established in 2018.
2018 Vadodara, Gujarat, India Active
Last Updated:
Access Report
About Zenocare Pharmaceuticals Private Limited

Zenocare Pharmaceuticals Private Limited, a active private limited company, was established on 09 January 2018 in Vadodara, Gujarat, India. Engaging in specialty within the trading sector, it holds CIN: U51909GJ2018PTC100439. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.20 M.

Its leadership includes Maniram Kushwaha (Additional Director), Nandkishor Kushwaha (Additional Director). Past directors included Khemraj, Praveen Srivastava. It is based at A-652,Akshar City Kelanpur, Vadodara, Gujarat, 390004.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909GJ2018PTC100439

  • Registration Number

    100439

  • Incorporation Date

    09 January 2018

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.20 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.20 M
  • Company Age 8 Year, 1 Month
Company report

Zenocare Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Zenocare Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Zenocare Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Maniram Kushwaha Additional Director 08 Sep 2018 Current
Nandkishor Kushwaha Additional Director 08 Sep 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 08 Sep 2018 Past
Pramod Abcsdd Director 05 Sep 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Zenocare Pharmaceuticals.

Enhance accessibility to Zenocare Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Zenocare Pharmaceuticals revenue growth over time
Zenocare Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Zenocare Pharmaceuticals?

Unlock access to Zenocare Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Zenocare Pharmaceuticals?

Unlock and access historical data on people associated with Zenocare Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Zenocare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenocare Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Zenocare Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Maniram Kushwaha was appointed as a Additional Director was appointed as a Additional Director on 08 Sep 2018 & has been associated with this company since 7 years 5 months . was documented.

  • Director Appointment

    The activity Nandkishor Kushwaha was appointed as a Additional Director was appointed as a Additional Director on 08 Sep 2018 & has been associated with this company since 7 years 5 months . was completed.

  • Company Incorporation

    Zenocare Pharmaceuticals Private Limited was registered on 09 Jan 2018 with Roc Ahmedabad & aged 8 years 1 month as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Zenocare Pharmaceuticals Private Limited?

The CIN of Zenocare Pharmaceuticals Private Limited is U51909GJ2018PTC100439.

Where is Zenocare Pharmaceuticals Private Limited headquartered?

Zenocare Pharmaceuticals Private Limited is headquartered at A-652,Akshar City Kelanpur, Vadodara, Gujarat, 390004.

When was Zenocare Pharmaceuticals Private Limited incorporated?

Zenocare Pharmaceuticals Private Limited was incorporated on 09 January 2018.

Who are the current directors of Zenocare Pharmaceuticals Private Limited?

The current directors of Zenocare Pharmaceuticals Private Limited are

What is the primary industry of Zenocare Pharmaceuticals Private Limited?

The primary industry of Zenocare Pharmaceuticals Private Limited is Trading.

Is Zenocare Pharmaceuticals Private Limited a listed company?

Zenocare Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Zenocare Pharmaceuticals Private Limited?

The authorized capital of Zenocare Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.20 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available